Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Proteins | 33 | 2022 | 245 | 9.250 |
Why?
|
| Biofilms | 18 | 2022 | 72 | 5.020 |
Why?
|
| Bacillus subtilis | 19 | 2022 | 49 | 4.850 |
Why?
|
| Acinetobacter baumannii | 8 | 2022 | 22 | 2.960 |
Why?
|
| DNA-Binding Proteins | 12 | 2019 | 700 | 2.930 |
Why?
|
| Imidazoles | 8 | 2017 | 175 | 2.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 10 | 2013 | 85 | 2.110 |
Why?
|
| Transcription Factors | 11 | 2022 | 753 | 2.010 |
Why?
|
| S100 Calcium Binding Protein G | 6 | 2012 | 21 | 1.360 |
Why?
|
| DNA, Bacterial | 2 | 2022 | 150 | 1.230 |
Why?
|
| Protein Kinases | 5 | 2015 | 122 | 1.130 |
Why?
|
| Protein Structure, Secondary | 10 | 2014 | 136 | 1.120 |
Why?
|
| Calcium | 5 | 2012 | 929 | 1.100 |
Why?
|
| Anti-Bacterial Agents | 9 | 2018 | 1026 | 1.070 |
Why?
|
| DNA | 6 | 2010 | 597 | 1.070 |
Why?
|
| Models, Molecular | 17 | 2018 | 546 | 1.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2022 | 50 | 1.000 |
Why?
|
| Protein Conformation | 12 | 2019 | 362 | 0.960 |
Why?
|
| Magnetic Resonance Spectroscopy | 11 | 2014 | 346 | 0.890 |
Why?
|
| Colistin | 2 | 2022 | 2 | 0.840 |
Why?
|
| Protein Binding | 13 | 2019 | 1027 | 0.810 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2022 | 98 | 0.810 |
Why?
|
| Molecular Docking Simulation | 4 | 2019 | 78 | 0.810 |
Why?
|
| Amino Acid Sequence | 15 | 2019 | 1083 | 0.770 |
Why?
|
| Mutation | 5 | 2022 | 1213 | 0.750 |
Why?
|
| Francisella | 2 | 2020 | 2 | 0.680 |
Why?
|
| Protein Structure, Tertiary | 12 | 2013 | 322 | 0.680 |
Why?
|
| Amides | 3 | 2015 | 86 | 0.650 |
Why?
|
| Heat-Shock Proteins | 2 | 2009 | 69 | 0.610 |
Why?
|
| Francisella tularensis | 1 | 2017 | 2 | 0.600 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2017 | 17 | 0.570 |
Why?
|
| Vibrio | 3 | 2013 | 14 | 0.570 |
Why?
|
| Adjuvants, Pharmaceutic | 2 | 2014 | 2 | 0.530 |
Why?
|
| Maprotiline | 1 | 2015 | 1 | 0.500 |
Why?
|
| Tularemia | 1 | 2015 | 4 | 0.500 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 7 | 2009 | 67 | 0.490 |
Why?
|
| Cross-Linking Reagents | 2 | 2013 | 80 | 0.490 |
Why?
|
| Cell Membrane Permeability | 1 | 2015 | 59 | 0.490 |
Why?
|
| Trans-Activators | 2 | 2007 | 237 | 0.460 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 1447 | 0.450 |
Why?
|
| Phosphotransferases | 1 | 2013 | 16 | 0.440 |
Why?
|
| Escherichia coli | 5 | 2011 | 368 | 0.440 |
Why?
|
| Signal Transduction | 5 | 2011 | 2689 | 0.440 |
Why?
|
| Crystallography, X-Ray | 3 | 2022 | 190 | 0.400 |
Why?
|
| Caspase 3 | 1 | 2012 | 233 | 0.400 |
Why?
|
| Bacillus anthracis | 1 | 2011 | 11 | 0.390 |
Why?
|
| Binding Sites | 9 | 2014 | 631 | 0.390 |
Why?
|
| Porifera | 1 | 2011 | 58 | 0.380 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2010 | 1 | 0.360 |
Why?
|
| Point Mutation | 1 | 2010 | 97 | 0.360 |
Why?
|
| Peptides | 3 | 2007 | 455 | 0.350 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 166 | 0.350 |
Why?
|
| Calbindins | 6 | 2012 | 23 | 0.340 |
Why?
|
| Environmental Exposure | 1 | 2012 | 269 | 0.340 |
Why?
|
| Virulence Factors | 2 | 2020 | 11 | 0.330 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2017 | 226 | 0.300 |
Why?
|
| Connexins | 1 | 2007 | 35 | 0.300 |
Why?
|
| Proteins | 2 | 2008 | 474 | 0.280 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 67 | 0.280 |
Why?
|
| Cloning, Molecular | 3 | 2018 | 357 | 0.280 |
Why?
|
| Hydrogen Bonding | 4 | 2012 | 67 | 0.270 |
Why?
|
| Magnesium | 2 | 2010 | 110 | 0.270 |
Why?
|
| Manganese | 1 | 2005 | 26 | 0.260 |
Why?
|
| Pyrroles | 3 | 2011 | 83 | 0.250 |
Why?
|
| Virulence | 3 | 2021 | 51 | 0.240 |
Why?
|
| Staphylococcus aureus | 3 | 2017 | 175 | 0.240 |
Why?
|
| Copper | 1 | 2005 | 149 | 0.230 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2017 | 133 | 0.230 |
Why?
|
| Protein Multimerization | 2 | 2014 | 71 | 0.230 |
Why?
|
| Structure-Activity Relationship | 4 | 2017 | 420 | 0.230 |
Why?
|
| Biopolymers | 1 | 2003 | 21 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1745 | 0.210 |
Why?
|
| Escherichia coli Proteins | 3 | 2010 | 65 | 0.200 |
Why?
|
| Histidine Kinase | 3 | 2007 | 4 | 0.200 |
Why?
|
| Amino Acid Motifs | 1 | 2022 | 77 | 0.200 |
Why?
|
| Protein Domains | 1 | 2022 | 74 | 0.200 |
Why?
|
| Indole Alkaloids | 2 | 2011 | 18 | 0.200 |
Why?
|
| Animals | 12 | 2020 | 20881 | 0.190 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2013 | 139 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2018 | 1200 | 0.190 |
Why?
|
| Caenorhabditis elegans | 2 | 2012 | 38 | 0.190 |
Why?
|
| Indoles | 2 | 2011 | 146 | 0.180 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 8 | 0.180 |
Why?
|
| Stress, Physiological | 1 | 2021 | 215 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 615 | 0.170 |
Why?
|
| Base Sequence | 3 | 2018 | 1015 | 0.170 |
Why?
|
| Bacteria | 2 | 2011 | 193 | 0.170 |
Why?
|
| Thermodynamics | 2 | 2010 | 162 | 0.160 |
Why?
|
| Circular Dichroism | 3 | 2007 | 99 | 0.150 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 129 | 0.140 |
Why?
|
| Small Molecule Libraries | 2 | 2014 | 53 | 0.140 |
Why?
|
| Spores, Bacterial | 2 | 2007 | 17 | 0.140 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 284 | 0.130 |
Why?
|
| Keratinocytes | 2 | 2014 | 68 | 0.130 |
Why?
|
| Thiazoles | 2 | 2014 | 95 | 0.130 |
Why?
|
| Glycolipids | 1 | 2014 | 20 | 0.120 |
Why?
|
| beta-Lactam Resistance | 1 | 2014 | 6 | 0.120 |
Why?
|
| RNA | 2 | 2007 | 171 | 0.120 |
Why?
|
| In Vitro Techniques | 2 | 2006 | 765 | 0.120 |
Why?
|
| Rats | 5 | 2014 | 5300 | 0.120 |
Why?
|
| Gram-Negative Bacteria | 1 | 2014 | 55 | 0.120 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2014 | 47 | 0.120 |
Why?
|
| Sequence Alignment | 3 | 2010 | 165 | 0.120 |
Why?
|
| Biological Products | 1 | 2014 | 78 | 0.110 |
Why?
|
| Cell Line | 3 | 2014 | 1752 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 2005 | 202 | 0.110 |
Why?
|
| Chromatography, Gel | 2 | 2003 | 79 | 0.110 |
Why?
|
| Cross Infection | 1 | 2015 | 195 | 0.110 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 120 | 0.110 |
Why?
|
| Peptides, Cyclic | 2 | 2014 | 35 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 742 | 0.100 |
Why?
|
| Tetrazolium Salts | 1 | 2012 | 36 | 0.100 |
Why?
|
| Fertility | 1 | 2012 | 60 | 0.100 |
Why?
|
| Toxicity Tests | 1 | 2012 | 26 | 0.100 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2011 | 7 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.100 |
Why?
|
| Biofouling | 1 | 2011 | 14 | 0.100 |
Why?
|
| Calbindin 1 | 2 | 2009 | 6 | 0.100 |
Why?
|
| Cysteine | 2 | 2009 | 112 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 791 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 55 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Second Messenger Systems | 1 | 2010 | 53 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 204 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2010 | 137 | 0.090 |
Why?
|
| Kinetics | 3 | 2007 | 1047 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2010 | 152 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2673 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 231 | 0.080 |
Why?
|
| Static Electricity | 1 | 2009 | 91 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 62 | 0.080 |
Why?
|
| Apoproteins | 2 | 2009 | 11 | 0.080 |
Why?
|
| Proteobacteria | 1 | 2008 | 3 | 0.080 |
Why?
|
| EF Hand Motifs | 2 | 2009 | 6 | 0.080 |
Why?
|
| Alkaloids | 1 | 2008 | 40 | 0.080 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.080 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2007 | 6 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 481 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 38 | 0.070 |
Why?
|
| Nitrogen Isotopes | 2 | 2004 | 13 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 62 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 137 | 0.070 |
Why?
|
| Deoxyribonuclease I | 1 | 2006 | 16 | 0.070 |
Why?
|
| Protein Folding | 1 | 2006 | 82 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1040 | 0.070 |
Why?
|
| Surface Properties | 1 | 2007 | 363 | 0.070 |
Why?
|
| Reference Standards | 1 | 2005 | 115 | 0.060 |
Why?
|
| Structural Homology, Protein | 1 | 2003 | 16 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 2003 | 17 | 0.060 |
Why?
|
| Molecular Structure | 3 | 2011 | 397 | 0.060 |
Why?
|
| Humans | 7 | 2017 | 68618 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2003 | 34 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 85 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 63 | 0.060 |
Why?
|
| ran GTP-Binding Protein | 1 | 2003 | 2 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2003 | 358 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 981 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 122 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 376 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 271 | 0.050 |
Why?
|
| Cathelicidins | 1 | 2020 | 11 | 0.040 |
Why?
|
| Moths | 1 | 2020 | 14 | 0.040 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2020 | 21 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2011 | 73 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2020 | 94 | 0.040 |
Why?
|
| Macrophages | 1 | 2020 | 647 | 0.030 |
Why?
|
| Marine Toxins | 1 | 2014 | 14 | 0.030 |
Why?
|
| Seawater | 1 | 2014 | 29 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 80 | 0.030 |
Why?
|
| Hemolysis | 1 | 2014 | 39 | 0.030 |
Why?
|
| Piperidines | 1 | 2014 | 123 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 128 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2014 | 109 | 0.030 |
Why?
|
| Female | 1 | 2015 | 38074 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 901 | 0.020 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2011 | 16 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 371 | 0.020 |
Why?
|
| Pepsin A | 1 | 2010 | 8 | 0.020 |
Why?
|
| Staphylococcal Protein A | 1 | 2010 | 15 | 0.020 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2010 | 11 | 0.020 |
Why?
|
| Novobiocin | 1 | 2010 | 6 | 0.020 |
Why?
|
| Enterococcus faecium | 1 | 2010 | 3 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2010 | 12 | 0.020 |
Why?
|
| Manganese Compounds | 1 | 2010 | 8 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 52 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2010 | 38 | 0.020 |
Why?
|
| Chlorides | 1 | 2010 | 68 | 0.020 |
Why?
|
| Drug Resistance, Multiple | 1 | 2010 | 56 | 0.020 |
Why?
|
| Tobramycin | 1 | 2010 | 38 | 0.020 |
Why?
|
| Triazoles | 1 | 2010 | 43 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 8474 | 0.020 |
Why?
|
| Thiourea | 1 | 2009 | 16 | 0.020 |
Why?
|
| Disulfides | 1 | 2009 | 40 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 260 | 0.020 |
Why?
|
| Urea | 1 | 2009 | 51 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 92 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 317 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2009 | 141 | 0.020 |
Why?
|
| Bordetella bronchiseptica | 1 | 2008 | 1 | 0.020 |
Why?
|
| Acylation | 1 | 2008 | 22 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 290 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2007 | 40 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2007 | 39 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 258 | 0.020 |
Why?
|
| Methionine | 1 | 2006 | 36 | 0.020 |
Why?
|
| Dimerization | 1 | 2005 | 99 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 567 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2004 | 54 | 0.010 |
Why?
|
| Hydrogen | 1 | 2004 | 35 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 108 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 214 | 0.010 |
Why?
|